ConductScience.org, home

Paper17655729

FLT3 inhibition in acute myeloid leukaemia.

Knapper S. Br J Haematol, 2007. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. FLT3 inhibition in acute myeloid leukaemia. Papers, record 17655729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17655729

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FLT3 inhibition in acute myeloid leukaemia.
PubMed
Journal
Br J Haematol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
1.11
iCite
Revised in PubMed
2009-11-19
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knapper SSteven

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Leukemia, MyeloidMajor topic
fms-Like Tyrosine Kinase 3Major topic
Acute Disease
HSP90 Heat-Shock Proteins
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Remission Induction

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
39367387AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.Exp Hematol Oncol2024https://conductscience.org/library/papers/39367387PubMed
34172833Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia.Commun Biol2021https://conductscience.org/library/papers/34172833PubMed
33832508Combating drug resistance in acute myeloid leukaemia by drug rotations: the effects of quizartinib and pexidartinib.Cancer Cell Int2021https://conductscience.org/library/papers/33832508PubMed
28895560Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia.Leukemia2018https://conductscience.org/library/papers/28895560PubMed
26438511Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.Blood2015https://conductscience.org/library/papers/26438511PubMed
26172401Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia.Leukemia2015https://conductscience.org/library/papers/26172401PubMed
25510283Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?Immunol Rev2015https://conductscience.org/library/papers/25510283PubMed
24749672Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia.Expert Opin Investig Drugs2014https://conductscience.org/library/papers/24749672PubMed
24468836Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?Curr Opin Hematol2014https://conductscience.org/library/papers/24468836PubMed
24280675Heat shock protein 90 and role of its chemical inhibitors in treatment of hematologic malignancies.Pharmaceuticals (Basel)2012https://conductscience.org/library/papers/24280675PubMed
23321254Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic target.Blood2013https://conductscience.org/library/papers/23321254PubMed
22927251Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia.Blood2012https://conductscience.org/library/papers/22927251PubMed
22797419FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia.Leukemia2013https://conductscience.org/library/papers/22797419PubMed
22754594Heat shock protein 90 inhibition: rationale and clinical potential.Ther Adv Med Oncol2012https://conductscience.org/library/papers/22754594PubMed
21788404Online nanoflow multidimensional fractionation for high efficiency phosphopeptide analysis.Mol Cell Proteomics2011https://conductscience.org/library/papers/21788404PubMed
21453545Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.J Hematol Oncol2011https://conductscience.org/library/papers/21453545PubMed
21080208Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo.Invest New Drugs2012https://conductscience.org/library/papers/21080208PubMed
20514303High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.J Korean Med Sci2010https://conductscience.org/library/papers/20514303PubMed
20019052A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia.Mol Cell Proteomics2010https://conductscience.org/library/papers/20019052PubMed
20007803FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.Blood2010https://conductscience.org/library/papers/20007803PubMed

See all 27 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
KMT2A4297PubTator's text mininghttps://conductscience.org/library/genes/4297NCBI Gene
RET5979PubTator's text mininghttps://conductscience.org/library/genes/5979NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17655729

GET https://conductscience.org/api/papers/v1/17655729/cited_by?page=2